Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
5.05
-0.10 (-1.94%)
At close: Feb 4, 2026, 4:00 PM EST
5.07
+0.02 (0.40%)
Pre-market: Feb 5, 2026, 8:04 AM EST
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $241.11 million as of February 5, 2026. Its market cap has increased by 90.78% in one year.
Market Cap
241.11M
Enterprise Value
65.86M
1-Year Change
90.78%
Ranking
Category
Stock Price
$5.05
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $241.11M, a decrease of -40.20%. That is a compound annual growth rate of -10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 241.11M | 26.25% |
| Dec 31, 2025 | 190.98M | 57.83% |
| Dec 31, 2024 | 121.00M | 62.54% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
| Aug 10, 2021 | 403.20M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 266.03M |
| Nautilus Biotechnology | 262.71M |
| Enlivex Therapeutics | 261.12M |
| OmniAb | 250.48M |
| Shattuck Labs | 243.63M |
| Heron Therapeutics | 242.96M |
| Cabaletta Bio | 241.63M |
| Palisade Bio | 235.43M |